Fed. Circ. Deems Purdue's Tramadol Patents Invalid
Purdue Pharma Products LP has lost its appeal of a district court ruling that the company's patents for tramadol are invalid, clearing the way for Par Pharmaceuticals Inc. to market a...To view the full article, register now.
Already a subscriber? Click here to view full article